Will I pay more for higher doses
Egecioglu, E
However, this risk may be higher in reality, as 10 to 20% of cases initially diagnosed as LM are later reclassified as LMM after further examination
However, patients should be advised to report symptoms suggestive of liver injury, including: Persistent nausea or vomiting unrelated to expected GI side effects Right upper quadrant abdominal pain (which may also indicate gallbladder disease, a known risk with GLP-1 therapy) Jaundice (yellowing of skin or eyes) Dark urine or pale stools Unexplained fatigue or malaise Clinicians should maintain a low threshold for investigating these symptoms with comprehensive liver function tests, including ALT, AST, alkaline phosphatase, bilirubin, albumin, and INR/prothrombin time
3.2 Ovarian granulosa cell ferroptosis and impaired follicular development Granulosa cells are the primary site of ovarian hormone synthesis and play a crucial role in regulating follicular development, oocyte maturation, and ovulation through hormone secretion
Based primarily on animal studies with supporting human imaging data, GLP-1 receptor activation in the ventral tegmental area and nucleus accumbens appears to modulate dopamine signaling in response to palatable foods, potentially decreasing the rewarding properties of high-calorie foods